Integrated Filing — IndAS



General information about company

Scrip Code 500164
NSE Symbol GODREJIND
MSEI Symbol NOTLISTED
ISIN INE233A01035
Name of company Godrej Industries Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-08-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 13-08-2026   12:30:00
End date and time of board meeting 13-08-2026   13:10:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 5,44,809.00 5,44,809.00
Other income 91,221.00 91,221.00
Total income 6,36,030.00 6,36,030.00
2 Expenses
(a) Cost of materials consumed 2,91,137.00 2,91,137.00
(b) Purchases of stock-in-trade 3,13,924.00 3,13,924.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (2,75,847.00) (2,75,847.00)
(d) Employee benefit expense 55,429.00 55,429.00
(e) Finance costs 74,514.00 74,514.00
(f) Depreciation, depletion and amortisation expense 13,337.00 13,337.00
(f) Other Expenses
1 Other Expenses 1,02,698.00 1,02,698.00
Total other expenses 1,02,698.00 1,02,698.00
Total expenses 5,75,192.00 5,75,192.00
3 Total profit before exceptional items and tax 60,838.00 60,838.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 60,838.00 60,838.00
6 Tax expense
7 Current tax 9,625.00 9,625.00
8 Deferred tax 11,259.00 11,259.00
9 Total tax expenses 20,884.00 20,884.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 39,954.00 39,954.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 12,382.00 12,382.00
16 Total profit (loss) for period 52,336.00 52,336.00
17 Other comprehensive income net of taxes (500.00) (500.00)
18 Total Comprehensive Income for the period 51,836.00 51,836.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 28,436.00 28,436.00
Total profit or loss, attributable to non-controlling interests 23,900.00 23,900.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 27,803.00 27,803.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 24,033.00 24,033.00
21 Details of equity share capital
Paid-up equity share capital 3,368.00 3,368.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 8.44 8.44
Diluted earnings (loss) per share from continuing operations 8.44 8.44
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.44 8.44
Diluted earnings (loss) per share from continuing and discontinued operations 8.44 8.44
24 Debt equity ratio 2.3800 2.3800
25 Debt service coverage ratio 1.6500 1.6500
26 Interest service coverage ratio 4.0200 4.0200
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above Statement of unaudited financial results which are published in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 13, 2026. The financial results are in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with the relevant rules thereunder. The above results have been reviewed by the Statutory Auditors of the Company who have expressed an unmodified review conclusion vide their review reports thereon. 2. During the quarter ended June 30, 2026, under the Employee Stock Grant Scheme, the Company has granted 35,998 stock grants to eligible employees of the Company. Upon vesting, as per the Scheme, equivalent number of equity shares of nominal value of Re. 1 each in the Company shall be issued to the eligible employees on exercising their grants. 3. On November 21, 2025 the Government of India notified four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 , and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Company/Group had assessed and disclosed the incremental impact of these changes basis actuarial valuation and management estimates and had accounted an additional gratuity and leave benefits liability of Rs. 65.81 crore in the Consolidated Financial results for the year ended March 31, 2026, as an Exceptional item. 4. Pursuant to the share purchase agreement with the Promoter Group of Creamline Dairy Products Limited, Godrej Agrovet Limited a subsidiary company, had acquired the balance equity stake of 36.79% during the quarter ended June 30, 2025 for Rs. 708.58 crore in Creamline Dairy Products Limited. During the quarter ended September 30, 2025, Godrej Agrovet Limited further acquired 0.46% equity stake for Rs. 8.93 crore thereby increasing the equity stake to 99.78% in Creamline Dairy Products Limited. As at June 30, 2026 Godrej Agrovet Limited is in the process of acquiring the balance 0.22% equity stake. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. 5. The Board of Directors of Astec LifeSciences Limited (Subsidiary Company of Godrej Agrovet Limited) at its meeting held on June 30, 2025, has inter-alia, approved the Letter of Offer and Rights Issue of 28,01,673 (Twenty Eight Lakh One Thousand Six Hundred and Seventy-Three) fully paid-up Equity Shares of face value of Rs. 10 (Ten) each, for an aggregate amount not exceeding Rs. 249.35 Crore (Rupees Two Hundred and Forty-Nine Crore and Thirty Five Lakh Only) at the issue price of Rs. 890/- (Rupees Eight Hundred and Ninety Only) per share in the Rights Entitlement ratio of 1 (One) fully paid-up rights equity share for every 7 (Seven) fully paid up equity share, of face value Rs. 10 (Ten) each, held by the eligible equity shareholders of Astec LifeSciences Limited as on Record date, July 04, 2025. The Issue opened on Monday, July 14, 2025 and closed on Monday, July 28, 2025. Other terms of the Issue were included in the Letter of Offer for the Issue. Accordingly, Godrej Agrovet Limited a subsidiary company had participated in the said Rights issue and equity shares have been allotted on July 29, 2025. Consequent to the rights issue, the shareholding % in Astec LifeSciences Limited has increased to 67.03% as at June 30, 2026. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. 6. The Hon'ble National Company Law Tribunal ('NCL T') dated 8 July 2026 has pronounced the order to merge Embellish Houses Private Limited (a wholly owned subsidiary of Godrej Properties Limited, a subsidiary company) with Godrej Properties Limited with effect from 1 November 2025 (the appointed date) along with directions to Godrej Properties Limited to file the certified copy of the Order, the scheme of amalgamation and some other compliance documents with the concerned Registrar of Companies ('RoC') post which the merger will be considered as effective. Godrej Properties Limited is in the process of completing the necessary formalities, within the timelines stipulated as per the order, post which the order will be considered as effective. Pending the process of making Scheme effective, the Group has not given effect to the NCLT order during the quarter ended 30 June 2026. 7. The Board of Directors of Godrej Capital Limited (Subsidiary Company of Godrej Investment Limited, a subsidiary company) , at its meeting held on July 03, 2026, approved a scheme of amalgamation of Godrej Finance Limited (Transferor Company) with Godrej Capital Limited (Transferee Company) in accordance with Section 233 and other applicable provisions of the Companies Act, 2013. The Transferor Company is wholly-owned subsidiary of the Transferee Company and, accordingly shares will be issued pursuant to the amalgamation. Further, the listed non-convertible debentures of the Transferor Company will be transferred to the Transferee Company without any change in their existing terms and conditions. Godrej Finance Limited has filed an application to the Reserve Bank of India in relation to the proposed scheme and approval is yet to be received. 8. Pursuant to SEBI Circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 read with Circular no. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 dated July 29, 2022, the Company and its subsidiary(ies) have listed Commercial Papers and listed Unsecured Non convertible debentures on concerned Stock Exchange(s). 9. Formulae used for Calculation of Key Ratios and Financial indicators: Debt Equity Ratio (Gross) = Total Debt /Equity Debt Equity Ratio (Net) = DEBT [Borrowings (excluding Lease Liabilities accounted as per Ind AS 116) - Cash and Bank Balance (includes FD) - Liquid Investments] / Equity Debt Service Coverage Ratio = EBITDA / [Interest Expense + Repayment of Long Term Borrowings during the period (netted off to the extent of Long term Loans availed during the same period for the repayments)] Interest Service Coverage Ratio = EBITDA / Interest Expense EBITDA = Net Profit/(Loss) Before Tax + Interest Expense + Depreciation and Amortisation Expenses+Loss/(Profit) (net) on sale of Property, Plant and Equipment Current Ratio = Current Assets/Current Liabilities Long term Debt to Working Capital = Non Current Borrowing / (Current assets-Current Liabilities) Bad Debts to Accounts Receivable Ratio = Bad Debts/Accounts Receivable Current Liability Ratio = Current Liabilities /Total Liabilities Total Debt to Total Assets = (Non Current Borrowing+Current Borrowing)/Total Assets Debtors Turnover = Revenue from Operations / Average Trade Receivable Inventory Turnover = (Cost of Materials Consumed + Purchases of Stock in Trade + Changes in Inventories of Finished Goods, Stock in Trade and Work in Progress) / Average Inventory Operating profit ratio = (Earnings before exceptional item, interest, taxes, depreciation, amortization expenses less Other Income/ Revenue from operations) Net Profit Margin = Profit/(Loss) for the period/ Revenue from Operations Net Worth= As defined in sub-section (57) of section 2 of the Companies Act,2013. For Table refer PDF filing done at Stock exchanges. 10. In view of acquisitions and changes in the Company’s / Group's shareholdings during the period in some of the subsidiaries, joint ventures and associates, the consolidated results for the current period are not strictly comparable with those of the previous periods. 11. The Company is in compliance with the requirements of the Chapter XII of SEBI Master circular dated October 15, 2025 applicable to Large Corporate Borrowers. 12. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the published year to date figures upto the third quarter of that financial year.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Chemicals 1,16,063.00 1,16,063.00
2 Animal Nutrition 1,30,209.00 1,30,209.00
3 Veg Oils 76,966.00 76,966.00
4 Estate and Property Development 1,33,486.00 1,33,486.00
5 Finance and Investments 96,563.00 96,563.00
6 Dairy 46,463.00 46,463.00
7 Crop Care 34,902.00 34,902.00
8 Hospitality 2,992.00 2,992.00
9 Others 13,501.00 13,501.00
Total Segment Revenue 6,51,145.00 6,51,145.00
Less: Inter segment revenue 15,115.00 15,115.00
Revenue from operations 6,36,030.00 6,36,030.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Chemicals 15,922.00 15,922.00
2 Animal Nutrition 8,469.00 8,469.00
3 Veg Oils 8,896.00 8,896.00
4 Estate and Property Development 50,182.00 50,182.00
5 Finance and Investments 10,041.00 10,041.00
6 Dairy (190.00) (190.00)
7 Crop Care 7,555.00 7,555.00
8 Hospitality 688.00 688.00
9 Others 713.00 713.00
Total Profit before tax 1,02,276.00 1,02,276.00
i. Finance cost 28,175.00 28,175.00
ii. Other Unallocable Expenditure net off Unallocable income 13,263.00 13,263.00
Profit before tax 60,838.00 60,838.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Chemicals 2,97,654.00 2,97,654.00
2 Animal Nutrition 2,20,307.00 2,20,307.00
3 Veg Oils 1,13,148.00 1,13,148.00
4 Estate and Property Development 88,15,074.00 88,15,074.00
5 Finance and Investments 35,81,604.00 35,81,604.00
6 Dairy 78,251.00 78,251.00
7 Crop Care 2,05,268.00 2,05,268.00
8 Hospitality 79,856.00 79,856.00
9 Others 63,856.00 63,856.00
Total Segment Asset 1,34,55,018.00 1,34,55,018.00
Un-allocable Assets 68,448.00 68,448.00
Net Segment Asset 1,35,23,466.00 1,35,23,466.00
4 Segment Liabilities
Segment Liabilities
1 Chemicals 93,749.00 93,749.00
2 Animal Nutrition 1,44,070.00 1,44,070.00
3 Veg Oils 17,887.00 17,887.00
4 Estate and Property Development 67,87,722.00 67,87,722.00
5 Finance and Investments 25,80,467.00 25,80,467.00
6 Dairy 36,092.00 36,092.00
7 Crop Care 1,03,968.00 1,03,968.00
8 Hospitality 76,640.00 76,640.00
9 Others 21,962.00 21,962.00
Total Segment Liabilities 98,62,557.00 98,62,557.00
Un-allocable Liabilities 12,90,824.00 12,90,824.00
Net Segment Liabilities 1,11,53,381.00 1,11,53,381.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) 1. Unallocable expenditure includes general and administrative expenses and other expenses incurred on common services at the corporate level and relate to the Group as a whole. 2. Others includes seeds business, poultry, cattle breeding, energy generation through windmills. 3. Segment Revenue Reconciliation in terms of the measure reported to the Chief Operating Decision Maker: For Table refer PDF filing done at Stock exchanges.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount of items that will not be reclassified to profit and loss 214.00 214.00
Total Amount of items that will not be reclassified to profit and loss 214.00
2 Income tax relating to items that will not be reclassified to profit or loss (20.00) (20.00)
3 Amount of items that will be reclassified to profit and loss
1 Amount of items that will be reclassified to profit and loss (512.00) (512.00)
Total Amount of items that will be reclassified to profit and loss (512.00)
4 Income tax relating to items that will be reclassified to profit or loss 222.00 222.00
5 Total Other comprehensive income (500.00) (500.00)





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Kalyaniwalla & Mistry LLP Yes 31-07-2027